异维A酸通过PPARγ信号通路损害睑板腺分泌功能
该研究以大鼠为对象,给予异维A酸20 mg/kg/d连续五个月,每月检测泪液分泌、荧光素染色和红外照相,末次处理后取组织行常规染色及实时聚合酶链反应、Western blot和免疫组化检测相关基因及产物。结果显示异维A酸虽未改变泪液分泌、未引起腺泡显著萎缩,但荧光素染色评分增加、睑板腺对比度显著降低、结膜杯状细胞减少,并显著抑制PPARγ通路表达。结论认为异维A酸通过PPARγ通路引起睑板腺功能障碍,影响睑板细胞分化及睑脂质和量的改变。
要点
- 异维A酸20 mg/kg/d处理五个月的大鼠泪液分泌无改变,但荧光素染色评分增加提示显著角膜受累。
- 异维A酸处理组睑板腺对比度显著降低,但未发现腺泡显著萎缩。
- 异维A酸显著抑制PPARγ通路表达,未引起FoxO1及炎症相关基因上调。
核心结论
- 异维A酸不引起睑板腺腺泡显著萎缩,也不引起睑板腺FoxO1表达的显著改变。
- 异维A酸通过PPARγ通路引起睑板腺功能障碍,影响睑板细胞分化及睑脂质和量的改变。
研究设计与样本
- 大鼠给予异维A酸20 mg/kg/d处理五个月,每月检测泪液分泌、荧光素染色和红外照相。
- 处理五个月后取组织行常规染色评估形态学改变,并行实时聚合酶链反应、Western blot和免疫组化检测相关基因及产物。
主要发现
- 全身方面,异维A酸处理大鼠体重显著低于对照组,并有明显皮肤损伤。
- 局部方面,泪液分泌无改变,但荧光素染色评分增加提示显著角膜受累,睑板腺对比度显著降低,未发现腺泡显著萎缩。
- 异维A酸引起结膜杯状细胞减少。
- 异维A酸处理未引起FoxO1及炎症相关基因上调,但显著抑制PPARγ通路表达。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the effects of isotretinoin on the ocular surface and to explore the possible mechanisms. METHODS: Rats were treated with isotretinoin 20 mg/kg/d for five months and tested monthly for tear secretion, fluorescein staining, and infrared photography. After five months of treatment, tissues were harvested for routine staining to evaluate the morphological changes; and real-time polymerase chain reaction, Western blot, and immunohistochemistry to study the expression of associated genes and their products such as forkhead box protein O1 (FoxO1), forkhead box protein O3, peroxisome proliferator-activated receptor γ (PPARγ), adipose differentiation-related protein, elongation of very long chain fatty acids protein 4, fatty acid binding protein 4, matrix metalloproteinase-9, and interleukin-6. RESULTS: Systemically, isotretinoin-treated rats have a significantly lower body weight that controls and apparent skin damage. Locally, although there was no alteration in tear secretion, a significant corneal involvement indicated by increased fluorescein staining scores, and also the contrast of meibomian gland was significantly reduced but no significant atrophy of the acinus was found. In addition, isotretinoin causes a decrease in conjunctival goblet cells. Furthermore, isotretinoin treatment did not cause the upregulation of FoxO1 and inflammation related genes but significantly suppressed the expression of PPARγ pathway. CONCLUSIONS: Isotretinoin does not cause a significant atrophy of the acinus and a significant change of FoxO1 expression in the meibomian gland. Isotretinoin causes meibomian gland dysfunction, affecting meibocyte differentiation and qualitative and quantitative changes in the meibum, through PPARγ pathway.
引用
- Zhang P, Tian L, Bao J, et al. Isotretinoin Impairs the Secretory Function of Meibomian Gland Via the PPARγ Signaling Pathway. Invest Ophthalmol Vis Sci. 2022. PMID: 35353124. doi:10.1167/iovs.63.3.29
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。